中晚期卵巢癌术后化疗的临床观察.doc

中晚期卵巢癌术后化疗的临床观察
陈静平 【摘要】 目的 分析两种给药途径 (顺铂 +紫杉醇静脉化疗 , 顺铂 +紫杉醇腹腔化疗 )对中晚期卵巢癌术后的化疗效果。方法 选择 2011年 6月至 2012年 6月本院收治的确诊为卵巢查 . 人民卫生出版社 , 2010:227-233.
[2] Rebecca Siegel, Deepa Naishadham, Ahmedin Jemal. Cancer Statistics, CANCER J CLIN, 2012,62:10-29.
[3] Martinek . , S. Kehoe. When should surgical cytoreduction in advanced ovarian cancer take place. Journal of Oncology, 2010.
[4] A, J., S. R, W. E. Cancer Statistics. CA Cancer J Clin, 2008, 58(2): 71-96.
[5] 崔恒 . 卵巢癌的早期诊断 . 中国妇产科临床杂志 , 2010, 11(6): 403-40.
[6] Suh DH, Kim JW, Kim K, et al. Major clinical research advances in gynecologic cancer in Gynecol Oncol, 2013, 24(1):66-82. [7] Bamias A, Bamia C, Zagouri F, et al. Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/ platinum chemotherapy: the impact of novel agents. Oncology, 2013, 84(3):158-65.
[8] Lee SE, Bairstow SF, Werling JO, et al. Paclitaxel nanosuspensions for targeted chemotherapy-nanosuspension preparation, characterization, and use. Pharm Dev Technol, 2013 Apr 25.
[9] . 北京:人民卫生出版社 , 2010:7293.
[10] Jordan S, Steer C, Defazio A, et al. Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer -A population-based study. Gynecol Oncol, 2013, 129(2):310-7.
[11] Landrum LM, Java J,